Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Portugal

 

Warsaw hub model set to spread across CEE

A new Warsaw Health Innovation Hub in Poland has seen 30 big pharma and medtech contribute brains and money to tackle healthcare projects, extending the cooperation which developed during Covid between the government and the private sector. Healthcare providers are set to join. The model is likely to be adopted by other CEE countries.
May 26, 2022

Lusiadas Saude sale latest

HBI hears that there has been progress in the sale of Lusiadas Saude, Portugal’s third-largest hospital group by revenue.
May 5, 2022

Affidea deal – underbidders and EBITDA

HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.
April 28, 2022

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.
April 19, 2022

Atrys: What’s the focus?

No listed health care group in Europe has grown anything like as fast as Atrys Health, which now spans Spain, Portugal, Switzerland and four Latin American countries. But does its M&A strategy have any coherence? We talk to Atrys CFO Josep Maria Huch.
April 11, 2022

KKR set to acquire IVI-RMA

Multiple sources say US-based buyout specialist KKR is close to closing a deal to buy Spain-based global fertility player IVI-RMA, the largest group in the sector by revenue.
March 31, 2022

Unilabs sale completes

AP Moller Holding, the investment company owned by the billionaire Maersk family, has closed the purchase of global lab and imaging chain Unilabs. 
March 23, 2022

Icade Sante considering H2 for IPO attempt part deux

At the end of last year, healthcare specialist REIT Icade Santé looked to fall victim to capital markets' apathy for European healthcare services, postponing its IPO. Could it be looking to try again in H2 2022 - or is it too soon to try?
March 23, 2022

Will record results for Synlab precipitate Cinven sale?

Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?
March 17, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us